Biotech · Private company
Miltenyi Biotec, Inc.
Track this companyFree. Adds Miltenyi Biotec, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Fast TILs to Treat Metastatic Cancer Patients With Pleural DiseasePHASE1 · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07192900 · fetched Nov 12, 2026
- CAR20.19.22 T-cells in Relapsed, Refractory B-cell MalignanciesPHASE1 · TERMINATED · started Jun 30, 2022ClinicalTrials.gov NCT05094206 · fetched Nov 12, 2026
- Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic LeukemiaPHASE2 · RECRUITING · started Apr 19, 2022ClinicalTrials.gov NCT05281809 · fetched Nov 12, 2026
- Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS DevicePHASE2 · ACTIVE_NOT_RECRUITING · started Oct 1, 2015ClinicalTrials.gov NCT02600208 · fetched Nov 12, 2026
- Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related DonorsNA · ACTIVE_NOT_RECRUITING · started Oct 1, 2014ClinicalTrials.gov NCT00959140 · fetched Nov 12, 2026
- Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood TransplantsAVAILABLEClinicalTrials.gov NCT01881334 · fetched Nov 12, 2026